ERCC2 and colorectal carcinoma: The opposite tendency was observed in male CRC patients, where the XPD rs238406_AA and AC genotypes were associated with a decreased risk of disease (OR 0.69, CI 0.47–0.99; and OR 0.51, CI 0.38–0.68, respectively).